Anzeige
Mehr »
Login
Donnerstag, 24.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Jetzt knallt's an der Börse! Diese Aktie hat das Zeug zum Überflieger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von MassDevice

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
17.04.CardioFocus reports successful pulsed field ablation cases
17.04.AMT Medical raises $25M Series B for heart bypass system
16.04.Medline wins FDA clearance for nitinol foot and ankle implants
16.04.Hyperfine enrolls initial patients in MRI study
16.04.NeuroOne says tariffs won't impact business, Zimmer Biomet deal
16.04.RadNet to acquire iCad
16.04.Glucotrack to bring implantable CBGM to automated insulin delivery system initiative in Europe
16.04.Abbott has mixed results in Q1
15.04.Terumo Neuro wins FDA nod for first dual-layer carotid stent
15.04.Imperative Care to kick off new trial of Zoom stroke treatment
15.04.Phantom Neuro raises $19M Series A for neural interface
15.04.DESKi wins FDA clearance for HeartFocus software
15.04.EBR wins FDA nod for leadless pacing system
15.04.CeriBell earns FDA nod for pediatric seizure detection software
15.04.Johnson & Johnson beats Street in Q1, raises 2025 guidance
15.04.Lifeward launches next-gen ReWalk 7 personal exoskeleton in the U.S.
14.04.BVI Medical names a new CCO
14.04.CMS proposes approval of additional payment for Sequana Medical's Alfapump
14.04.Spectrum Vascular bolsters executive team with new CEO, CCO
14.04.Johnson & Johnson MedTech completes first cases with Ottava surgical robot
14.04.Edwards wins CE mark for Sapien M3, world's first approved transfemoral heart valve
11.04.Cook Medical invests $3.4M in Ireland facility sustainability
11.04.Cagent Vascular initiates balloon angioplasty study
11.04.Retractable Technologies cuts workforce to reduce reliance on China amid trade war
11.04.Fire1 heart failure system performs well in first-in-human study